Drug intelligence / Profile preview

flower pollen extract

Development stage
Unknown
Lead developer
Graminex
Modality
Small Molecules
Administration
Oral
01

Overview

**Flower pollen extract** is a standardized botanical drug product derived primarily from grass pollens including rye grass, corn, and timothy grass, most commonly formulated as the Graminex pollen extract mixture containing pollen-pistil extract PI 82 and purified pollen extract GC FEM. It has been developed and marketed as a phytotherapeutic oral product for chronic prostatitis chronic pelvic pain syndrome and benign prostatic hyperplasia, with additional use in menopausal and premenstrual symptom management. The exact molecular target is not well defined; available preclinical and clinical literature supports a multimodal anti-inflammatory and anti-proliferative pharmacology, and reports indicate lack of meaningful estrogenic activity in products used for menopausal symptoms. Overall, it is best characterized as a botanical small-molecule complex or nutraceutical-like phytotherapeutic with a favorable safety profile and symptomatic benefit rather than a single-target pharmaceutical.

Brand names
CerniltonRelizenSerelysFemalFemalenGraminex
Other names
flower pollen extractpollen extractpollen-pistil extractgrass pollen extract

Beyond the preview

Go deeper on flower pollen extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on flower pollen extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call